Aptose Biosciences (APTO) Stock Analysis

What Aptose Biosciences does

Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO-253 is currently undergoing Phase 1a/b clinical evaluation for patients battling relapsed or treatment-resistant blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another compound, HM43239, is progressing through Phase 1/2 clinical trials, specifically targeting individuals with relapsed or refractory AML. Furthermore, luxeptinib is in Phase 1a/b clinical testing, designed to treat patients suffering from recurring or treatment-resistant B-cell malignancies—such as chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas—as well as AML and HR MDS. Aptose also has APL-581 under development, a program centered on a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor. The company has established strategic agreements with CrystalGenomics, Inc. and OHM Oncology. Incorporated in 1986, Aptose Biosciences Inc. previously operated as Lorus Therapeutics Inc. before adopting its current name in August 2014. Its corporate headquarters are located in Toronto, Canada.

Key metrics

ETFs linked to APTO

Broad-market and Healthcare sector ETFs an investor holding Aptose Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how APTO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Aptose Biosciences?

Aptose Biosciences trades under the ticker APTO on NASDAQ.

Which exchange is APTO listed on?

APTO is listed on NASDAQ.

What sector does Aptose Biosciences operate in?

Aptose Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze APTO in a portfolio?

PortView shows APTO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.